TAG
IgG4-related disease
Zenas BioPharma Earmarks $118M to Fund Immunotherapy Project
Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies, today announced proceeds of $118...